Becker's Healthcare June 6, 2023
Noah Schwartz

Google has emerged as a major healthcare disruptor, and GV, a venture capital arm now independent from Google, has been extremely active in the healthcare sector since 2009.

Here are the 143 healthcare companies in GV’s portfolio:

  • 23andMe
  • Accent Therapeutics
  • Adagio Therapeutics
  • Aera Therapeutics
  • Affinia Therapeutics
  • Alector
  • Aledade
  • Ankyra Therapeutics
  • Antiva Biosciences
  • Arcus Biosciences
  • Arda Therapeutics
  • Areteia Therapeutics
  • ARMO BioSciences
  • Arrakis
  • Arsanis
  • Aspen Neuroscience
  • Aspire Health
  • Autolus
  • Beam Therapeutics
  • BlackThorn Therapeutics
  • Brightline
  • Cala Health
  • Cambridge Epigenetix
  • CareBridge
  • Carrick Therapeutics
  • Celsius Therapeutics
  • Cerevance
  • Chroma Medicine
  • Clear Labs
  • Clever Care
  • Clover Health
  • Collective Health
  • Comanche Biopharma
  • Compass Therapeutics
  • Contraline
  • Curie.Bio
  • Decibel Therapeutics
  • Denali Therapeutics
  • Diverge Health
  • DNAnexus
  • Doctor On Demand
  • Dyno Therapeutics
  • Editas Medicine
  • Encoded Therapeutics
  • EQRx
  • Evelo Biosciences
  • Evox...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Trends
March Fundraising Roundup: 7 Provider Tech Startups That Closed Rounds This Month
Pelago Defies Digital Health Funding Drought, Raises $58M
Digital health venture capital deals stagnate
Boundless Bio’s ‘BOLD’ IPO Reels In $100M for a New Kind of Cancer Drug
Is AI’s next big leap understanding emotion? $50M for Hume says yes

Share This Article